The diagnostic performance of copeptin in clinical practice: A prospective study.
Penelope TrimpouIoannis BouniasOlof EhnOla HammarstenOskar RagnarssonPublished in: Clinical endocrinology (2024)
Copeptin >4.0 pmol/L after an overnight WDT can be used to rule out cDI and copeptin ≥21 pmol/L at baseline to diagnose nDI. The diagnostic performance of copeptin in the context of the WDT is otherwise limited in the diagnostic work-up of patients with polyuria-polydipsia syndrome.
Keyphrases